Clinical Trial (Interventional)

Results 151 - 175 of 403
Public Title Project Description Modified
A prospective, multicenter, comparative, open label, randomized phase III study to assess immunogeni . . . Open label, randomized, controlled, multicenter, four-arm, parallel, comparative, phase III study wi . . . 05 May 2016 02:08:52
Effects of Nutrient-fortified Milk-based Formula on the Nutritional Status and Psychomotor Skills of . . . This randomized, controlled trial examined the effects of nutrient fortified milk-based formula supp . . . 18 Sep 2014 09:11:16
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Ca . . . The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect . . . 23 Sep 2019 08:54:52
A Multinational Study Comparing The Long-term Efficacy And Safety Of Two Medicines, Solifenacin Succ . . . The purpose of this study is to examine how well the combination of two medicines (solifenacin succi . . . 05 May 2016 02:07:55
A Clinical Trial To Evaluate Efficacy For Patients With Primary Liver Cancer Scheduled To Be Treated . . . This is a randomized, double blind, dummy controlled multicenter trial to evaluate the efficacy and . . . 18 Mar 2015 01:39:58
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study To Evalu . . . This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the effi . . . 09 Aug 2016 09:30:44
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy And Safety Of FG-4592 . . . This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in anemic subject . . . 02 Aug 2019 09:43:38
LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute c . . . The randomization schedules will be center-based and stratified to account for subjects’ NSTEMI/S . . . 05 May 2016 02:06:45
MK-8835/PF-04971729 And Sitagliptin Co-administration Factorial Study This is a randomized double-blind, parallel-group, factorial study of co-administration of ertuglif . . . 11 Nov 2014 02:29:59
To Demonstrate Equivalence Of Pharmacokinetics And Noninferiority Of Efficacy For CT-P10 In Comparis . . . This is a Phase 1/3 prospective, randomised, parallel-group, active controlled,double-blind, multice . . . 30 May 2016 03:19:18
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment . . .   This is a biosimilar study that compares the efficacy of rituximab-Pfizer to rituximab-EU when a . . . 24 Jul 2018 10:14:46
Clinical Study To Evaluate The Safety, Immunogenicity And Efficacy Of Investigational Flu Vaccine Co . . . Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Co . . . 07 Nov 2014 10:22:18
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Co . . .  To evaluate the safety and efficacy of reformulated raltegravir (MK-0518) 1200 mg once daily in co . . . 04 Oct 2018 09:59:24
BI695501 compared to adalimumab in patients with active rheumatoid arthritis Clinical Phase: IIIDuration of treatment: Each patient will be treated with either BI 695501 or US-s . . . 14 Aug 2015 01:24:06
A Phase 3 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of . . . Assess the efficacy, safety and tolerability of moxifloxacin 400 mg plus PA‐824 100 mg plus pyrazi . . . 05 May 2016 02:05:22
Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-posi . . . In this study, participants with programmed cell death ligand 1 (PD-L1)-positive non-small cell lung . . . 24 May 2019 03:09:46
Kailee This is a Phase III, randomized, multicenter, multinational, two-arm, open-label clinical trial. The . . . 12 May 2017 01:14:30
SYGMA2 This study will recruit patients worldwide at approximately 330 sites in about 25 countries. The tar . . . 16 Apr 2015 03:28:52
Reduced-dosed rivaroxaban in the long-term prevention of recurrent symptomatic VTE This is a multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven stud . . . 22 Dec 2014 02:34:50
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subje . . . This Phase IIIb, randomized, open-label, parallel group, active control, multicenter, treat to-targ . . . 30 May 2016 03:22:09
Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes . . . This Phase IIIb, randomized, double-blind, parallel-group, placebo-controlled, multicenter, treat-to . . . 06 Jan 2015 12:00:49
A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter study of the efficacy and safety of . . . Study A0081042 is a double-blind, placebo controlled, randomized, parallel group, multicenter study . . . 28 Jan 2015 09:11:17
Norspan Asian Trial Chronic non-malignant pain is a common cause of adult disability. There is growing evidence that opi . . . 09 Feb 2015 09:44:29
Randomized, double-blind, placebo-controlled, multicenter study comparing ciprofloxacin DPI 32.5 mg . . . After a maximum screening period of 4 weeks, eligible subjects will be randomized to one of 4 possib . . . 18 Dec 2018 10:35:08
The International Polycap Study 3 - TIPS-3  Investigators from Canada, China, Malaysia and the Philippines designed the TIPS-3 study. Today, it . . . 10 Aug 2015 01:20:30

Copyright © One Window Project 2018. All rights reserved.